Chenny Zhang
Director @ Cerberus Capital Management
Chenny Zhang is a Series A investor at Cerberus Capital Management focused on Life Science and Therapeutics. Chenny Zhang is the Board of Directors of Syntis Bio.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 75%
Last updated:
For AI agents: llms.txt
Industries Chenny Zhang invests in
Stages Chenny Zhang invests in
Countries Chenny Zhang invests in
Investment Focus
Industry
- Life Science 2 (50%)
- Therapeutics 2 (50%)
- Biotechnology 2 (50%)
- Medical 1 (25%)
- Biopharma 1 (25%)
Stage
- Series A 2 (50%)
- Seed 1 (25%)
- Series B 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Virchow Medical
|
Virchow Medical is a manufacturer and supplier of biopsy catchment devices. | $4.1M / Seed / Mar 24, 2026 | |
Ansa Biotechnologies
|
Ansa Biotechnologies is manufactured via a chemical method that has remained essentially unchanged for 35 years and has approached a plateau. Ansa Biotechnologies is developing a novel DNA synthesis technology based on enzymes that will be more fast, accurate, and clean than existing methods. The technique promises to dramatically accelerateinnovation in biological research and engineering. | $46.4M / Series B / Oct 01, 2025 | |
Syntis Bio
|
Syntis Bio operates as a late-stage preclinical company intended to develop a new class of therapy. The company's drug uses novel formulations for oral therapies that target specific tissues, enabling users to increase bioavailability. | $33M / Series A / Jul 01, 2025 | |
Tierra Biosciences
|
Tierra Biosciences is a synthetic biology company that accelerates the pace of discovery and enables the next generation of bio-based materials. Tierra’s first product, the Tierra Protein Platform, couples high-throughput protein manufacturing with the simplicity of e-commerce to make ordering custom proteins easier than ever before. By loweringthe traditional protein synthesis barrier, Tierra serves scientists looking to change the world with novel proteins. Led by a team of protein experts, this fast-growing company is transforming the way people discover, screen, and develop proteins for future bio-based products. For more information, visit tierrabiosciences.com. | $11.4M / Series A / Mar 12, 2024 |
Co-Investors
Material Impact
2 deals together
Alternative Investment Management
1 deal together
Altitude Life Science Ventures
1 deal together
Apollo Labs
1 deal together
Black Opal Ventures
1 deal together
Blue Water Life Science Advisors
1 deal together
About Cerberus Capital Management
Cerberus Capital Management is a private investment firm that focuses on operational private equity investments. The firm manages funds and accounts for many of the world’s most respected investors.
Cerberus Capital Management Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Morgan Mahlock
Director
|
|||
Amir Salek
Senior Managing Director
|
|||
|
Brett Ingersoll
President, Chief Investment Officer
|
|||
|
Chenny Zhang
Director
|
|||
David Mcwilliam
Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Chenny Zhang invest in?
Chenny Zhang invests primarily in Life Science, Therapeutics and Biotechnology startups, most often at Series A and Seed stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Chenny Zhang last invest?
The most recent investment recorded for Chenny Zhang closed in Mar 2026. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
